| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3791758 | Medical Clinics of North America | 2007 | 16 Pages |
Abstract
Myocardial infarction is a key component of the burden of cardiovascular disease. The assessment of the incidence and case fatality of myocardial infarction are important determinants of the decline in coronary disease mortality. The change in biomarkers used to diagnose myocardial infarction raises several methodologic, clinical, and public health challenges, which are discussed herein.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Véronique L. Roger,